A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipationLynn R. Webster, Mark Sostek, Sunita Dhar et al.|Pain|2013Cited by 116